Abstract:3-Deoxy-3-fluoro-D-glucopyranose crystallizes from acetone to give a unit cell containing two crystallographically independent molecules. One of these molecules (at site A) is structurally homogeneous and corresponds to 3-deoxy-3-fluoro-β-D-glucopyranose, C(6)H(11)FO(5), (I). The second molecule (at site B) is structurally heterogeneous and corresponds to a mixture of (I) and 3-deoxy-3-fluoro-α-D-glucopyranose, (II); treatment of the diffraction data using partial-occupancy oxygen at the anomeric center gave a high-quality packing model with an occupancy ratio of 0.84:0.16 for (II):(I) at site B. The mixture of α- and β-anomers at site B appears to be accommodated in the lattice because hydrogen-bonding partners are present to hydrogen bond to the anomeric OH group in either an axial or equatorial orientation. Cremer-Pople analysis of (I) and (II) shows the pyranosyl ring of (II) to be slightly more distorted than that of (I) [θ((I)) = 3.85 (15)° and θ((II)) = 6.35 (16)°], but the general direction of distortion is similar in both structures [ϕ((I)) = 67 (2)° (B(C1,C4)) and ϕ((II)) = 26.0 (15)° ((C3)TB(C1)); B = boat conformation and TB = twist-boat conformation]. The exocyclic hydroxymethyl (-CH(2)OH) conformation is gg (gauche-gauche) (H5 anti to O6) in both (I) and (II). Structural comparisons of (I) and (II) to related unsubstituted, deoxy and fluorine-substituted monosaccharides show that the gluco ring can assume a wide range of distorted chair structures in the crystalline state depending on ring substitution patterns.

2-Acetylamino-1,3,4,6-tetra-o-(trimethylsilyl)-2-deoxy-α-d-glucopyranose

2-Acetyl-amino-1,3,4,6-tetra-O-(tri-methyl-silyl)-2-de-oxy-α-d-gluco-pyran-ose.

3,4-Dicyanophenyl 2,3,4,6-Tetra-o-acetyl-α-d-glucopyranoside

3,4-Dicyanophenyl 2,3,4,6-tetra-<i>O</i>-acetyl-α-<scp>D</scp>-glucopyranoside

1,3-Dioxo-2,3-dihydro-1h-isoindol-2-yl 2,3,4-Tri-o-acetyl-β-d-xyloside.

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

2,3,4,6-Tetra-o-acetyl-1-o-(4-methoxy-cinnamo-yl)-β-d-glucopyran-ose.

Co-crystals of 3-deoxy-3-fluoro-α-D-glucopyranose and 3-deoxy-3-fluoro-β-D-glucopyranose

4-Deoxy-4-fluoro-β-D-glucopyranose

(E)-Dimethyl 4-(Ethylamino)-5-styrylfuran-2,3-dicarboxylate

2,3,4-Tri-o-acetyl-β-d-xylosyl 2,4-Dichloro-phenoxy-acetate.

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

2-Hydroxy-n-(2,3,4,6-tetra-o-pivaloyl-β-d-glucopyranosyl)benzylideneamine

(E)-Dimethyl 4-butylamino-5-(4-methylstyryl)-furan-2,3-dicarboxylate

Dimethyl 2-(4-Fluorophenyl)-3-(methylamino)-furan-4,5-dicarboxylate

2-(2-Chloro-phen-yl)-N-cyclo-hexyl-2-oxoacetamide.

Ethyl 2-Anilino-4-(2,4-dichlorophenyl)6-trifluoromethyl-3,4-dihydropyrimidine5 -Carboxylate

Glucosyl Anthranilate.

N-[2-(Aminosulfonyl)-5,6-Dihydro-6-Methyl-7,7-Dioxo-4h-Thieno[2,3-B]Thio Pyran-4-Yl] Acetamide

Methyl beta-D-galactopyranosyl-(1-->4)-beta-D-allopyranoside tetrahydrate